CareDx to Present at the Jefferies Virtual Healthcare Conference
CareDx, Inc. (Nasdaq: CDNA) announced its participation in the Jefferies Virtual Healthcare Conference on June 3, 2020, at 11:00 AM EDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CareDx, Inc. (Nasdaq: CDNA) announced its participation in the Jefferies Virtual Healthcare Conference on June 3, 2020, at 11:00 AM EDT. The company, recognized for its precision medicine solutions for transplant patients, will provide a live webcast of its presentation available on its investor website. CareDx focuses on developing and commercializing high-value healthcare solutions and offers a range of products and services to support transplant patients and their caregivers.
Details
News Market Reaction – CDNA
The recorded move for CDNA in the trading session of this news was -0.82%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., May 28, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the company will be participating in the upcoming Jefferies Virtual Healthcare Conference.
CareDx’s management is scheduled to present on Wednesday, June 3, 2020 at 11:00 AM Eastern Daylight Time (EDT). Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at https://investors.caredxinc.com/.
About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
For more information, please visit: www.CareDx.com.
CONTACTS:
Greg Chodaczek
347-620-7010
investor@caredx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.